DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Seiwert TY. et al.
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.
Lancet Oncol 2016;
17: 956-965
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.